Scott James G, Jhetam Sarah, Chen Renee, Daglish Mark
Faculty of Medicine, The University of Queensland, Herston, QLD, and; Metro North Mental Health, Royal Brisbane and Women's Hospital, Herston, Brisbane, QLD, and; Queensland Centre for Mental Health Research, Wacol, Brisbane, QLD, Australia.
Faculty of Science, The University of Queensland, St Lucia, QLD, Australia.
Australas Psychiatry. 2019 Aug;27(4):392-395. doi: 10.1177/1039856219859271. Epub 2019 Jun 27.
To examine the position statement of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) regarding the availability of electronic cigarettes in Australia.
There is limited evidence supporting the efficacy of nicotine e-cigarettes as an effective tobacco harm-reduction or cessation strategy for people with mental illness. The recommendations to increase their availability under regulation must be balanced with the physical and mental health risks of vapour inhalation and nicotine use, particularly for youth. Future recommendations by the RANZCP in relation to e-cigarettes must consider both the available evidence for harm reduction and the potential risks associated with youth e-cigarette use.
研究澳大利亚和新西兰皇家精神科医学院(RANZCP)关于澳大利亚电子烟供应情况的立场声明。
仅有有限证据支持尼古丁电子烟作为一种有效的烟草危害降低或戒烟策略对患有精神疾病的人有效。在监管下增加其供应的建议必须与吸入蒸汽和使用尼古丁对身心健康造成的风险相权衡,尤其是对年轻人而言。RANZCP未来关于电子烟的建议必须同时考虑减少危害的现有证据以及与年轻人使用电子烟相关的潜在风险。